Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'tumor cell lines' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 484 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Wang, ZX; Duan, WL; Wiebe, LI; Balzarini, J; De Clercq, E; Knaus, EE
      Synthesis of 1-(2-deoxy-beta-D-ribofuranosyl)-2,4-difluoro-5-substituted-benzene thymidine mimics, some related alpha-anomers, and their evaluation as antiviral and anticancer agents

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    2. Sonneveld, P; List, AF
      Chemotherapy resistance in acute myeloid leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    3. Sepp-Lorenzino, L; Tjaden, G; Moasser, MM; Timaul, N; Ma, Z; Kohl, NE; Gibbs, JB; Oliff, A; Rosen, N; Scher, HI
      Farnesyl : protein transferase inhibitors as potential agents for the management of human prostate cancer

      PROSTATE CANCER AND PROSTATIC DISEASES
    4. Cefai, D; Schwaninger, R; Balli, M; Brunner, T; Gimmi, CD
      Functional characterization of Fas ligand on tumor cells escaping active specific immunotherapy

      CELL DEATH AND DIFFERENTIATION
    5. Dillman, RO; Beutel, LD; De Leon, C; Nayak, SK
      Short-term tumor cell lines from breast cancer for use as autologous tumorcell vaccines in the treatment of breast cancer

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    6. Bergman, I; Barmada, MA; Griffin, JA; Slamon, DJ
      Treatment of meningeal breast cancer xenografts in the rat using an anti-P185/HER2 antibody

      CLINICAL CANCER RESEARCH
    7. Maliepaard, M; van Gastelen, MA; Tohgo, A; Hausheer, FH; van Waardenburg, RCAM; de Jong, LA; Pluim, D; Beijnen, JH; Schellens, JHM
      Circumvention of breast cancer resistance protein (BCRP)-mediated resistance to camptothecins in vitro using non-substrate drugs or the BCRP inhibitor GF120918

      CLINICAL CANCER RESEARCH
    8. Kovar, J; Valenta, T; Stybrova, H
      Differing sensitivity of tumor cells to apoptosis induced by iron deprivation in vitro

      IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
    9. Jones, HA; Hahn, SM; Bernhard, E; McKenna, WG
      Ras inhibitors and radiation therapy

      SEMINARS IN RADIATION ONCOLOGY
    10. Taylor, MM; Shimosawa, T; Samson, WK
      Endocrine and metabolic actions of adrenomedullin

      ENDOCRINOLOGIST
    11. Efferth, T; Dunstan, H; Sauerbrey, A; Miyachi, H; Chitambar, CR
      The anti-malarial artesunate is also active against cancer

      INTERNATIONAL JOURNAL OF ONCOLOGY
    12. Lee, MJ; Lee, JS; Lee, MC
      Apoptosis of skeletal muscle on steroid-induced myopathy in rats

      JOURNAL OF KOREAN MEDICAL SCIENCE
    13. McPhee, MM; Kerwin, SM
      Synthesis, DNA cleavage, and cytotoxicity of a series of bis(propargylic) sulfone crown ethers

      BIOORGANIC & MEDICINAL CHEMISTRY
    14. Kokotos, G; Constantinou-Kokotou, V; Padron, JM; Peters, GJ
      Synthesis and in vitro cytotoxicity of novel long chain busulphan analogues

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    15. Ozawa, Y; Sugi, NH; Nagasu, T; Owa, T; Watanabe, T; Koyanagi, N; Yoshino, H; Kitoh, K; Yoshimatsu, K
      E7070, a novel sulphonamide agent with potent antitumour activity in vitroand in vivo

      EUROPEAN JOURNAL OF CANCER
    16. Gelderblom, H; Verweij, J; Nooter, K; Sparreboom, A
      Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation

      EUROPEAN JOURNAL OF CANCER
    17. Johansson, S; Lindholm, P; Gullbo, J; Larsson, P; Bohlin, L; Claeson, P
      Cytotoxicity of digitoxin and related cardiac glycosides in human tumor cells

      ANTI-CANCER DRUGS
    18. Dorr, RT; Liddil, JD; Sami, SM; Remers, W; Hersh, EM; Alberts, DS
      Preclinical antitumor activity of the azonafide series of anthracene-basedDNA intercalators

      ANTI-CANCER DRUGS
    19. Fukushima, S; Takeuchi, Y; Kishimoto, S; Yamashita, S; Uetsuki, K; Shirakawa, S; Suzuki, M; Furuta, K; Noyori, R; Sasaki, H; Kikuchi, Y; Kita, T; Yamori, T; Sawada, J; Kojima, M; Hazato, A; Kurozumi, S; Fukushima, M
      Antitumor activity, optimum administration method and pharmacokinetics of 13,14-dihydro-15-deoxy-Delta(7)-prostaglandin A(1) methyl ester (TEI-9826) integrated in lipid microspheres (Lipo TEI-9826)

      ANTI-CANCER DRUGS
    20. Short, SC; Kelly, J; Mayes, CR; Woodcock, M; Joiner, MC
      Low-dose hypersensitivity after fractionated low-dose irradiation in vitro

      INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
    21. Martinez, A; Hodge, DL; Garayoa, M; Young, HA; Cuttitta, F
      Alternative splicing of the proadrenomedullin gene results in differentialexpression of gene products

      JOURNAL OF MOLECULAR ENDOCRINOLOGY
    22. Motohashi, N; Shirataki, Y; Kawase, M; Tani, S; Sakagami, H; Satoh, K; Kurihara, T; Nakashima, H; Wolfard, K; Miskolci, C; Molnar, J
      Biological activity of kiwifruit peel extracts

      PHYTOTHERAPY RESEARCH
    23. Rait, AS; Pirollo, KF; Rait, V; Krygier, JE; Xiang, LM; Chang, EH
      Inhibitory effects of the combination of HER-2 antisense oligonucleotide and chemotherapeutic agents used for the treatment of human breast cancer

      CANCER GENE THERAPY
    24. Baselga, J; Albanell, J
      Mechanism of action of anti-HER2 monoclonal antibodies

      ANNALS OF ONCOLOGY
    25. Piccart, MJ
      Proposed treatment guidelines for HER2-positive metastatic breast cancer in Europe

      ANNALS OF ONCOLOGY
    26. Navarro, E; Alonso, SJ; Alonso, PJ; Trujillo, J; Jorge, E; Perez, C
      Pharmacological effects of elenoside, an arylnaphthalene lignan

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    27. Uchiyama-Kokubu, N; Watanabe, T; Cohen, D
      Intracellular levels of two cyclosporin derivatives valspodar (PSC 833) and cyclosporin a closely associated with multidrug resistance-modulating activity in sublines of human colorectal adenocarcinoma HCT-15

      JAPANESE JOURNAL OF CANCER RESEARCH
    28. DiPaola, RS; Patel, J; Rafi, MM
      Targeting apoptosis in prostate cancer

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    29. Epner, DE
      Can dietary methionine restriction increase the effectiveness of chemotherapy in treatment of advanced cancer?

      JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
    30. Horiuchi, H; Inoue, T; Furusawa, S; Matsuda, H
      Characterization and expression of three forms of cDNA encoding chicken platelet-derived growth factor-A chain

      GENE
    31. Kostova, I; Manolov, I; Karaivanova, M
      Synthesis, physicochemical characterization, and cytotoxic screening of new zirconium complexes with coumarin derivatives

      ARCHIV DER PHARMAZIE
    32. Nielsen, D; Maare, C; Eriksen, J; Litman, T; Skovsgaard, T
      Expression of P-glycoprotein associated protein in Ehrlich fractionated and multidrug resistance ascites tumor cells after irradiation

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    33. McMillan, TJ; Tobi, S; Mateos, S; Lemon, C
      The use of DNA double-strand break quantification in radiotherapy

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    34. Joiner, MC; Marples, B; Lambin, P; Short, SC; Turesson, I
      Low-dose hypersensitivity: Current status and possible mechanisms

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    35. Hector, S; Bolanowska-Higdon, W; Zdanowicz, J; Hitt, S; Pendyala, L
      In vitro studies on the mechanisms of oxaliplatin resistance

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    36. Lee, MC; Lee, JS; Lee, MJ; Lee, JH; Kim, HI
      Fas mediates apoptosis in steroid-induced myopathy of rats

      NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
    37. Giermasz, A; Nowis, D; Jalili, A; Basak, G; Marczak, M; Makowski, M; Czajka, A; Mlynarczuk, I; Hoser, G; Stok, T; Lewandowski, S; Jakobisiak, M
      Antitumor activity of tributyrin in murine melanoma model

      CANCER LETTERS
    38. Ozawa, F; Friess, H; Kleeff, J; Xu, ZW; Zimmermann, A; Sheikh, MS; Buchler, MW
      Effects and expression of TRAIL and its apoptosis-promoting receptors in human pancreatic cancer

      CANCER LETTERS
    39. Weinstein, JN
      Searching for pharmacogenomic markers: The synergy between omic and hypothesis-driven research

      DISEASE MARKERS
    40. Sakagami, H; Arakawa, H; Maeda, M; Satoh, K; Kadofuku, T; Fukuchi, K; Gomi, K
      Production of hydrogen peroxide and methionine sulfoxide by epigallocatechin gallate and antioxidants

      ANTICANCER RESEARCH
    41. Shirataki, Y; Tani, S; Sakagami, H; Satoh, K; Nakashima, H; Gotoh, K; Motohashi, N
      Relationship between cytotoxic activity and radical intensity of isoflavones from Sophora species

      ANTICANCER RESEARCH
    42. Shi, YQ; Fukai, T; Sakagami, H; Kuroda, J; Miyaoka, R; Tamura, M; Yoshida, N; Nomura, T
      Cytotoxic and DNA damage-inducing activities of low molecular weight phenols from rhubarb

      ANTICANCER RESEARCH
    43. Shirataki, Y; Motohashi, N; Tani, S; Sakagami, H; Satoh, K; Nakashima, H; Mahapatra, SK; Ganguly, K; Dastidar, SG; Chakrabarty, AN
      In vitro biological activity of prenylflavanones

      ANTICANCER RESEARCH
    44. Prendergast, GC
      Farnesyltransferase inhibitors define a role for RhoB in controlling neoplastic pathophysiology

      HISTOLOGY AND HISTOPATHOLOGY
    45. van Zuylen, L; Verweij, J; Sparreboom, A
      Role of formulation vehicles in taxane pharmacology

      INVESTIGATIONAL NEW DRUGS
    46. Chen, ZP; Pan, J; Huang, Q; Sun, ZF; Zhou, LY; Wang, AD
      Antitumor efficacy of SarCNU in a human glioma xenograft model expressing both MGMT and extraneuronal monoamine transporter

      JOURNAL OF NEURO-ONCOLOGY
    47. Iwasa, K; Moriyasu, M; Yamori, T; Turuo, T; Lee, DU; Wiegrebe, W
      In vitro cytotoxicity of the protoberberine-type alkaloids

      JOURNAL OF NATURAL PRODUCTS
    48. Shi, YQ; Fukai, T; Sakagami, H; Chang, WJ; Yang, FQ; Wang, FP; Nomura, T
      Cytotoxic flavonoids with isoprenoid groups from Morus mongolica

      JOURNAL OF NATURAL PRODUCTS
    49. Lips, J; Kaina, B
      DNA double-strand breaks trigger apoptosis in p53-deficient fibroblasts

      CARCINOGENESIS
    50. Atsumi, T; Iwakura, I; Fujisawa, S; Ueha, T
      Reactive oxygen species generation and photo-cytotoxicity of eugenol in solutions of various pH

      BIOMATERIALS
    51. Lamb, DJ; Weigel, NL; Marcelli, M
      Androgen receptors and their biology

      VITAMINS AND HORMONES - ADVANCES IN RESEARCH AND APPLICATIONS, VOL 62
    52. Kawata, T; Durante, M; Furusawa, Y; George, K; Ito, H; Wu, H; Cucinotta, FA
      Rejoining of isochromatid breaks induced by heavy ions in G(2)-phase normal human fibroblasts

      RADIATION RESEARCH
    53. Amundson, SA; Bittner, M; Meltzer, P; Trent, J; Fornace, AJ
      Induction of gene expression as a monitor of exposure to ionizing radiation

      RADIATION RESEARCH
    54. Demetzos, C; Dimas, K; Hatziantoniou, S; Anastasaki, T; Angelopoulou, D
      Cytotoxic and anti-inflammatory activity of labdane and cis-clerodane typediterpenes

      PLANTA MEDICA
    55. Ali, M; Ansari, SH; Grever, MR
      Cytotoxic alkaloids from Tylophora indica

      PHARMAZIE
    56. Baselga, J
      Herceptin((R)) alone or in combination with chemotherapy in the treatment of HER2-positive metastatic breast cancer: Pivotal trials

      ONCOLOGY
    57. Huang, CH; Treat, J
      New advances in lung cancer chemotherapy: Topotecan and the role of topoisomerase I inhibitors

      ONCOLOGY
    58. Seidenfaden, R; Hildebrandt, H
      Retinoic acid-induced changes in polysialyltransferase mRNA expression andNCAM polysialylation in human neuroblastoma cells

      JOURNAL OF NEUROBIOLOGY
    59. Shao, L; Lewin, NE; Lorenzo, PS; Hu, ZJ; Enyedy, IJ; Garfield, SH; Stone, JC; Marner, FJ; Blumberg, PM; Wang, SM
      Iridals are a novel class of ligands for phorbol ester receptors with modest selectivity for the RasGRP receptor subfamily

      JOURNAL OF MEDICINAL CHEMISTRY
    60. Fan, Y; Shi, LM; Kohn, KW; Pommier, Y; Weinstein, JN
      Quantitative structure-antitumor activity relationships of camptothecin analogues: Cluster analysis and genetic algorithm-based studies

      JOURNAL OF MEDICINAL CHEMISTRY
    61. Arons, E; Kunin, V; Schechter, C; Ehrlich, R
      Organization and functional analysis of the mouse transporter associated with antigen processing 2 promoter

      JOURNAL OF IMMUNOLOGY
    62. Wang, BL; Xiong, QH; Shi, Q; Tan, D; Le, XD; Xie, KP
      Genetic disruption of host nitric oxide synthase II gene impairs melanoma-induced angiogenesis and suppresses pleural effusion

      INTERNATIONAL JOURNAL OF CANCER
    63. Wildi, S; Kleeff, J; Maruyama, H; Maurer, CA; Buchler, MW; Korc, M
      Overexpression of activin A in stage IV colorectal cancer

      GUT
    64. Barbieri, F; Sparatore, F; Cagnoli, M; Bruzzo, C; Novelli, F; Alama, A
      Antiproliferative activity and interactions with cell-cycle related proteins of the organotin compound triethyltin(IV)lupinylsulfide hydrochloride

      CHEMICO-BIOLOGICAL INTERACTIONS
    65. Szpaderska, AM; Frankfater, A
      An intracellular form of cathepsin B contributes to invasiveness in cancer

      CANCER RESEARCH
    66. Miki, K; Xu, MX; Gupta, A; Ba, Y; Tan, YY; Al-Refaie, W; Bouvet, M; Makuuchi, M; Moossa, AR; Hoffman, RM
      Methioninase cancer gene therapy with selenomethionine as suicide prodrug substrate

      CANCER RESEARCH
    67. Gupta, AK; Bakanauskas, VJ; Cerniglia, GJ; Chen, Y; Bernhard, EJ; Muschel, RJ; McKenna, WG
      The Ras radiation resistance pathway

      CANCER RESEARCH
    68. End, DW; Smets, G; Todd, AV; Applegate, TL; Fuery, CJ; Angibaud, P; Venet, M; Sanz, G; Poignet, H; Skrzat, S; Devine, A; Wouters, W; Bowden, C
      Characterization of the antitumor effects of the selective farnesyl protein transferase inhibitor R115777 in vivo and in vitro

      CANCER RESEARCH
    69. Johnson, JI; Decker, S; Zaharevitz, D; Rubinstein, LV; Venditti, J; Schepartz, S; Kalyandrug, S; Christian, M; Arbuck, S; Hollingshead, M; Sausville, EA
      Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials

      BRITISH JOURNAL OF CANCER
    70. Liu, WK; Ho, JCK; Ng, TB
      Suppression of cell cycle progression by a fungal lectin: activation of cyclin-dependent kinase inhibitors

      BIOCHEMICAL PHARMACOLOGY
    71. Burger, AM; Mengs, U; Schuler, JB; Fiebig, HH
      Antiproliferative activity of an aqueous mistletoe extract in human tumor cell lines and xenografts in vitro

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    72. Kairouz, R; Daly, RJ
      Tyrosine kinase signalling in breast cancer - Modulation of tyrosine kinase signalling in human breast cancer through altered expression of signalling intermediates

      BREAST CANCER RESEARCH
    73. Skehan, P
      Dealing with the data deluge in high throughput screening

      JOURNAL OF AUTOMATED METHODS & MANAGEMENT IN CHEMISTRY
    74. Karigiannis, G; Papaioannou, D
      Structure, biological activity and synthesis of polyamine analogues and conjugates

      EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
    75. Collett, ED; Davidson, LA; Lupton, JR; Chapkin, RS
      Dietary fish oil reduces colon cancer risk

      CURRENT ORGANIC CHEMISTRY
    76. Sebti, SM; Hamilton, AD
      Farnesyltransferase and geranylgeranyltransferase I inhibitors in cancer therapy: important mechanistic and bench to bedside issues

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    77. Bell, IM
      Inhibitors of protein prenylation 2000

      EXPERT OPINION ON THERAPEUTIC PATENTS
    78. Cho-Chung, YS
      Antisense and therapeutic oligonucleotides: toward a gene-targeting cancerclinic

      EXPERT OPINION ON THERAPEUTIC PATENTS
    79. Dowling, CR; Risbridger, GP
      The role of inhibins and activins in prostate cancer pathogenesis

      ENDOCRINE-RELATED CANCER
    80. Li, GC; Alexander, H; Schneider, N; Alexander, S
      Molecular basis for resistance to the anticancer drug cisplatin in Dictyostelium

      MICROBIOLOGY-UK
    81. Ferle-Vidovic, A; Potjak-Blazi, M; Rapic, V; Skare, D
      Ferrocenes (F168, F169) and fero-sorbitol-citrate (FSC): Potential anticancer drugs

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    82. Chastagner, P; Merlin, JL; Marchal, C; Hoffstetter, S; Barberi-Heyob, M; Vassal, G; Duprez, A
      In vivo potentiation of radiation response by topotecan in human rhabdomyosarcoma xenografted into nude mice

      CLINICAL CANCER RESEARCH
    83. Scherf, U; Ross, DT; Waltham, M; Smith, LH; Lee, JK; Tanabe, L; Kohn, KW; Reinhold, WC; Myers, TG; Andrews, DT; Scudiero, DA; Eisen, MB; Sausville, EA; Pommier, Y; Botstein, D; Brown, PO; Weinstein, JN
      A gene expression database for the molecular pharmacology of cancer

      NATURE GENETICS
    84. Prendergast, GC; Oliff, A
      Farnesyltransferase inhibitors: antineoplastic properties, mechanisms of action, and clinical prospects

      SEMINARS IN CANCER BIOLOGY
    85. Tsai, SW; Sun, YY; Williams, LE; Raubitschek, AA; Wu, AM; Shively, JE
      Biodistribution and radioimmunotherapy of human breast cancer xenografts with radiometal-labeled DOTA conjugated anti-HER2/neu antibody 4D5

      BIOCONJUGATE CHEMISTRY
    86. Hill, BT; Perrin, D; Kruczynski, A
      Inhibition of RAS-targeted prenylation: protein farnesyl transferase inhibitors revisited

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    87. Cedervall, B; Persson, L; Polischouk, A; Lange, CS
      Perspective on biological dosimetry from the aspect of individual radiosensitivity: the context of DNA double-strand breaks and chromosomal aberrations

      APPLIED RADIATION AND ISOTOPES
    88. Jia, GF; Lown, JW
      Design, synthesis and cytotoxicity evaluation of 1-chloromethyl-5-hydroxy-1,2-dihydro-3H-benz[e]indole (seco-CBI) dimers

      BIOORGANIC & MEDICINAL CHEMISTRY
    89. Jiang, B; Gu, XH
      Syntheses and cytotoxicity evaluation of bis(indolyl)thiazole, bis(indolyl)pyrazinone and bis(indolyl)pyrazine: Analogues of cytotoxic marine bis(indole) alkaloid

      BIOORGANIC & MEDICINAL CHEMISTRY
    90. Wang, CC; Lai, JE; Chen, LG; Yen, KY; Yang, LL
      Inducible nitric oxide synthase inhibitors of Chinese herbs. Part 2: Naturally occurring furanocoumarins

      BIOORGANIC & MEDICINAL CHEMISTRY
    91. Avivi-Green, C; Polak-Charcon, S; Madar, Z; Schwartz, B
      Apoptosis cascade proteins are regulated in vivo by high intracolonic butyrate concentration: Correlation with colon cancer inhibition

      ONCOLOGY RESEARCH
    92. Dowsett, M; Cooke, T; Ellis, I; Gullick, WJ; Gusterson, B; Mallon, E; Walker, R
      Assessment of HER2 status in breast cancer: why, when and how?

      EUROPEAN JOURNAL OF CANCER
    93. Prendergast, GC
      Farnesyltransferase inhibitors: antineoplastic mechanism and clinical prospects

      CURRENT OPINION IN CELL BIOLOGY
    94. Sebti, SM; Hamilton, AD
      Farnesyltransferase and geranylgeranyltransferase I inhibitors and cancer therapy: Lessons from mechanism and bench-to-bedside translational studies

      ONCOGENE
    95. Irby, RB; Yeatman, TJ
      Role of Src expression and activation in human cancer

      ONCOGENE
    96. Miki, K; Xu, MX; An, ZL; Wang, XE; Yang, M; Al-Refaie, W; Sun, XH; Baranov, E; Tan, YY; Chishima, T; Shimada, H; Moossa, AR; Hoffman, RM
      Survival efficacy of the combination of the methioninase gene and methioninase in a lung cancer orthotopic model

      CANCER GENE THERAPY
    97. Johnson, RC; Ricci, A; Cartun, RW; Ackroyd, R; Tsongalis, GJ
      p185(HER2) overexpression in human breast cancer using molecular and immunohistochemical methods

      CANCER INVESTIGATION
    98. Zujewski, J; Horak, ID; Bol, CJ; Woestenborghs, R; Bowden, C; End, DW; Piotrovsky, VK; Chiao, J; Belly, RT; Todd, A; Kopp, WC; Kohler, DR; Chow, C; Noone, M; Hakim, FT; Larkin, G; Gress, RE; Nussenblatt, RB; Kremer, AB; Cowan, KH
      Phase I and pharmacokinetic study of farnesyl protein transferase inhibitor R115777 in advanced cancer

      JOURNAL OF CLINICAL ONCOLOGY
    99. Bugelski, PJ; Atif, U; Molton, S; Toeg, I; Lord, PG; Morgan, DG
      A strategy for primary high throughput cytotoxicity screening in pharmaceutical toxicology

      PHARMACEUTICAL RESEARCH
    100. Kellner, U; Rudolph, P; Parwaresch, R
      Human DNA-topoisomerases - Diagnostic and therapeutic implications for cancer

      ONKOLOGIE


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/05/20 alle ore 04:17:11